Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Vericel Corporation logo

Vericel Corporation

Sector: Healthcare   

Industry: Biotechnology

46.42
 
USD
  
1.04
  
(2.29%)
Optionable: Yes  Market Cap: 2,295 M  90-day average vol: 451,594

Previous close: 45.38  Open: 45.59  Bid: 44.27  Ask: 47.67
52 week range    
29.24   
   53.05
Peers   
RPRX / 
NEOG / 
INIS / 
Last updated: Wednesday 24th April 2024
48
MarketXLS Rank
40
Value
46
Technical
60
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ICCC

0 B8158.065

INIS

0 B11.60.099

NEOG

4 B68.835.59

RPRX

0.018917 B20.640.19
Financials

VCEL Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AcquiredInProcessRnDIncome48 M
Amortization of intangibles-200000.0-300000.0-300000.0625000.0
Basic EPS from continuing operations-0.220.06-0.16-0.35
Basic EPS total0.12-0.220.06-0.16-0.35
Basic weighted shares outstanding3 M12 M24 M23 M33 M40 M44 M45 M46 M47 M
Cost of sales-4000.0-17 M-26 M-28 M-30 M-32 M38 M40 M50 M55 M
Depreciation-489000.0-752000.0-1 M-2 M-2 M-1 M2 M2 M3 M4 M
DepreciationAndAmortization-489000.0-752000.0-1 M-2 M-2 M-1 M2 M2 M3 M4 M
Diluted EPS total-6.95-2.23-0.97-1.18-0.52-0.2-0.220.06-0.16-0.35
Diluted normalized net income/share-0.220.06-0.16-0.35
Diluted weighted shares outstanding5 M9 M17 M17 M33 M41 M47 M46 M47 M
Earnings from equity interest7 M2 M
EarningsFromEquityInterestNetOfTax7 M2 M
GainOnSaleOfBusiness43 M
GeneralAndAdministrativeExpense-1000000.0-2 M-5 M-5 M-6 M-5 M61 M69 M98 M107 M
Gross operating profit15000.012 M25 M26 M34 M59 M80 M84 M106 M110 M
ImpairmentOfCapitalAssets3 M
Income before tax36 M-20 M-16 M-20 M-17 M-8 M-10 M3 M-8 M-16 M
Income restructuring and M&A-408000.0-3 M-100000.0
Income taxes27000.0-352000.0-57000.0-56000.0-12 M-839000.0-484000.0180000.0-111000.0721000.0
Interest income16000.024000.036000.08000.014000.0897000.02 M691000.0224000.01 M
InterestExpenseNonOperating11000.06000.09000.0314000.092000.031000.020000.06000.04000.0366000.0
InterestExpenseOperating-226000.0-931000.0-2 M-8000.0-6000.0
MiscOtherSpecialCharges5 M-29000.0371000.0-15000.0-2 M-5 M-8000.02 M3 M762000.0
Net income from total operations36 M-20 M-16 M-20 M-17 M-8 M-10 M3 M-7 M-17 M
NetIncomeCommonStockholders36 M-20 M-16 M-20 M-17 M-8 M-10 M3 M-7 M-17 M
NetIncomeContinuousOperations36 M-20 M-16 M-20 M-17 M-8 M-10 M3 M-7 M-17 M
NetNonOperatingInterestIncomeExpense5000.018000.027000.0-306000.0-78000.0866000.02 M685000.0220000.0975000.0
Normalized income-8 M-13 M
Operating income-21 M-24 M-17 M-17 M-15 M-4 M-11 M2 M-8 M-17 M
Operating income before depreciation (EBITDA)36 M-19 M-15 M-18 M-17 M-9 M-6 M10 M793000.0-7 M
OperatingExpense-21 M-35 M-41 M-45 M-49 M-63 M92 M82 M114 M127 M
Other income net-55 M-3 M-371000.015000.02 M5 M8000.0-2 M-3 M-762000.0
OtherGandA-1000000.0-2 M-5 M-5 M-6 M-5 M61 M69 M98 M107 M
OtherOperatingExpenses5 M6 M7 M7 M
OtherunderPreferredStockDividend-5 M-6 M-7 M-8 M
PreferredStockDividends-5 M-6 M-7 M-8 M
RentAndLandingFees-1000000.0-2 M-5 M-5 M-6 M-5 M
Research & development expense15 M21 M19 M15 M13 M14 M30 M13 M16 M20 M
ResearchExpense15 M21 M19 M15 M13 M14 M30 M13 M16 M20 M
RestructringAndMnAIncome-408000.0-3 M-100000.0
Revenue per share-200000.0-300000.0-300000.0625000.0
Selling Gen & administrative expense6 M14 M22 M27 M36 M49 M61 M69 M98 M107 M
SellingAndMarketingExpense6 M14 M22 M27 M36 M49 M
SellingExpense6 M14 M22 M27 M36 M49 M
Special income/charges408000.03 M-3 M
Total Income available for interest expense (EBIT)36 M-20 M-16 M-19 M-18 M-10 M-10 M3 M-8 M-16 M
Total common shares outstanding6 M24 M24 M33 M36 M44 M45 M46 M47 M47 M
Total net income36 M-20 M-16 M-20 M-17 M-8 M-10 M3 M-7 M-17 M
Total ordinary shares48 M48 M48 M48 M48 M48 M48 M48 M48 M48 M
Total revenues19000.029 M51 M54 M64 M91 M118 M122 M153 M164 M
TotalExpenses-21 M-52 M-68 M-74 M-79 M-95 M129 M122 M164 M181 M
TotalRevenue19000.029 M51 M54 M63 M91 M118 M124 M156 M164 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University